Reactions Weekly

, Volume 1696, Issue 1, pp 189–189 | Cite as

Ibrutinib

Richter's transformation of chronic lymphocytic leukaemia to large B-cell lymphoma after development of drug resistance: case report
Case report
  • 13 Downloads

Reference

  1. Sharma S, et al. Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL. Oncotarget 7: 68833-68841, No. 42, 18 Oct 2016. Available from: URL: http://doi.org/10.18632/oncotarget.11932 - USACrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations